Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 576 clinical trials
Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

To determine if the use of Prostate-Specific Membrane Antigen Positron Emission Computer Tomography (PSMA PET/CT) as a selection tool for performing extended lymph node dissection (ePLND) for

  • 0 views
  • 25 Aug, 2021
  • 1 location
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

This study evaluates the value of Gallium-68 labeled PSMA (68Ga-PSMA) for PET/CT imaging of prostate cancer recurrence. 68Ga-PSMA is a radioactive molecule, which binds to prostate cancer cells

ct scan
brachytherapy
68ga-psma-11
prostatectomy
prostate adenocarcinoma
  • 0 views
  • 26 Feb, 2022
  • 1 location
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection (GuideView)

histopathology assessments. Approximately 195 participants will be enrolled to ensure that at least 156 participants are evaluable (i.e. have both an evaluable PET/CT scan and histopathology assessment

  • 0 views
  • 23 Jul, 2022
  • 10 locations
Screening for Cancer in Patients With Unprovoked VTE

Open and multicenter randomized clinical trial (1:1) comparing limited screening with extended screening with the performance of Positron emission tomography-computed tomography (PET-CT) scan in

embolism
clot
thrombosis
deep vein thrombosis
deep venous thrombosis of lower extremity
  • 0 views
  • 18 Dec, 2021
  • 9 locations
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)

> Hypothesis: The radiation dose and treatment volume can be safely reduced from 30 Gy to 20 Gy while maintaining high rates of local control in patients who had a negative PET-CT scan following rituximab

ct scan
high grade b-cell lymphoma
anthracyclines
chemoimmunotherapy
rituximab
  • 8 views
  • 27 Jul, 2022
  • 13 locations
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma (RADAR)

Eligible patients will be randomised to receive either ABVD or A2VD chemotherapy. An interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt

lymphoma
doxorubicin
ejection fraction
classical hodgkin lymphoma
vinblastine
  • 2 views
  • 09 Jun, 2022
  • 7 locations
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma (SURVEILL'ORL)

imaging including PET-CT for patients N2) performed 2 to 4 months after the end of treatment. The randomization ratio is 1:1.

squamous cell carcinoma
cancer
  • 0 views
  • 03 Mar, 2022
Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism (MVTEP2/SOME2)

occult cancer especially based on FDG PET/CT, and suggests that the best target population for cancer screening would be patients with unprovoked VTE older than 50 years of age (6.7% in patients aged 50

cancer
  • 26 views
  • 22 Mar, 2022
  • 15 locations
18F-DOPA II - PET Imaging Optimization

A single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients (less than 18 years

dementia
parkinson's disease
dopa
  • 8 views
  • 03 May, 2022
  • 1 location
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

PET/CT) can further detect tumors. Eligibility People ages 12 and older with VHL that causes tumors and cysts to grow in the pancreas Design

genetic testing
ct scan
pet/ct scan
dotatate
neuroendocrine tumor
  • 0 views
  • 29 Jul, 2022
  • 1 location